{"id":"https://openalex.org/W1969486352","doi":"https://doi.org/10.1080/1042819031000116706","title":"Anti-B4 Blocked Ricin Post Chemotherapy in Patients with Chronic Lymphocytic Leukemia--Long-term Follow-up of a Monoclonal Antibody-based Approach to Residual Disease","display_name":"Anti-B4 Blocked Ricin Post Chemotherapy in Patients with Chronic Lymphocytic Leukemia--Long-term Follow-up of a Monoclonal Antibody-based Approach to Residual Disease","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W1969486352","doi":"https://doi.org/10.1080/1042819031000116706","mag":"1969486352","pmid":"https://pubmed.ncbi.nlm.nih.gov/14692524"},"language":"en","primary_location":{"id":"doi:10.1080/1042819031000116706","doi":"https://doi.org/10.1080/1042819031000116706","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1042819031000116706","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia &amp; Lymphoma","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1969486352"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044840107","display_name":"Apostolia Maria Tsimberidou","orcid":"https://orcid.org/0000-0003-2713-233X","observed_orcids":["https://orcid.org/0000-0003-2713-233X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Apostolia M. Tsimberidou","raw_affiliation_strings":["Department of Leukemia, MD Anderson Cancer Center, University of Texas, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, USA","Investigational Cancer Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, MD Anderson Cancer Center, University of Texas, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Investigational Cancer Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061285204","display_name":"Francis Joseph Giles","orcid":"https://orcid.org/0000-0002-6919-0231","observed_orcids":["https://orcid.org/0000-0002-6919-0231"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francis J. Giles","raw_affiliation_strings":["Department of Leukemia, MD Anderson Cancer Center University of Texas Holcombe Boulevard Unit 428 77030 Houston TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, MD Anderson Cancer Center University of Texas Holcombe Boulevard Unit 428 77030 Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["Department of Leukemia, MD Anderson Cancer Center University of Texas Holcombe Boulevard Unit 428 77030 Houston TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, MD Anderson Cancer Center University of Texas Holcombe Boulevard Unit 428 77030 Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027575595","display_name":"Michael J. Keating","orcid":"https://orcid.org/0000-0002-9121-6450","observed_orcids":["https://orcid.org/0000-0002-9121-6450"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael J. Keating","raw_affiliation_strings":["Department of Leukemia, MD Anderson Cancer Center University of Texas Holcombe Boulevard Unit 428 77030 Houston TX USA","University of Texas MD Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, MD Anderson Cancer Center University of Texas Holcombe Boulevard Unit 428 77030 Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006104041","display_name":"Susan Mary O'Brien","orcid":"https://orcid.org/0000-0002-2481-7504","observed_orcids":["https://orcid.org/0000-0002-2481-7504"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan M. O'Brien","raw_affiliation_strings":["Department of Leukemia, MD Anderson Cancer Center University of Texas Holcombe Boulevard Unit 428 77030 Houston TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, MD Anderson Cancer Center University of Texas Holcombe Boulevard Unit 428 77030 Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":0.4835,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.6263152,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"44","issue":"10","first_page":"1719","last_page":"1725"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9535999894142151,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.04399999976158142,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.8489999771118164},{"id":"https://openalex.org/keywords/residual-disease","display_name":"residual disease","score":0.6899999976158142},{"id":"https://openalex.org/keywords/immunotoxins","display_name":"immunotoxins","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.7080000042915344},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.859000027179718},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.5550000071525574},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.6669999957084656},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.36399999260902405},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7749999761581421},{"id":"https://openalex.org/keywords/hamas","display_name":"Hamas","score":0.5529999732971191},{"id":"https://openalex.org/keywords/hara","display_name":"haras","score":0.8349999785423279},{"id":"https://openalex.org/keywords/infusion-toxicity","display_name":"infusion toxicity","score":0.4300000071525574},{"id":"https://openalex.org/keywords/elevated-liver-enzymes","display_name":"elevated liver enzymes","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C2777200438","wikidata":"https://www.wikidata.org/wiki/Q408668","display_name":"Ricin","level":3,"score":0.8622295260429382},{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.7577474117279053},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7416504621505737},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.655034601688385},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5792412161827087},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5568185448646545},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.5513293147087097},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.509760320186615},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.47839152812957764},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4542544186115265},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4325811266899109},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3595360815525055},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3382895290851593},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3320237696170807},{"id":"https://openalex.org/C2777367657","wikidata":"https://www.wikidata.org/wiki/Q184651","display_name":"Toxin","level":2,"score":0.21712526679039001},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16601231694221497},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012276","descriptor_name":"Ricin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012276","descriptor_name":"Ricin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/1042819031000116706","doi":"https://doi.org/10.1080/1042819031000116706","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1042819031000116706","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia &amp; Lymphoma","raw_type":"journal-article"},{"id":"pmid:14692524","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14692524","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W13898768","https://openalex.org/W60865865","https://openalex.org/W109232360","https://openalex.org/W183581174","https://openalex.org/W196527825","https://openalex.org/W288660874","https://openalex.org/W1489775606","https://openalex.org/W1505534997","https://openalex.org/W1548735291","https://openalex.org/W1862030292","https://openalex.org/W1893092074","https://openalex.org/W1952075956","https://openalex.org/W1967789322","https://openalex.org/W1979300931","https://openalex.org/W1988217711","https://openalex.org/W2026864697","https://openalex.org/W2049437000","https://openalex.org/W2063948016","https://openalex.org/W2070193300","https://openalex.org/W2115568708","https://openalex.org/W2137804513","https://openalex.org/W2144827965","https://openalex.org/W2161926682","https://openalex.org/W2206113074","https://openalex.org/W2267215445","https://openalex.org/W2326175431","https://openalex.org/W3041047318","https://openalex.org/W4237443037"],"related_works":["https://openalex.org/W288660874","https://openalex.org/W1893092074","https://openalex.org/W1862030292","https://openalex.org/W1514205868","https://openalex.org/W13898768","https://openalex.org/W2267215445","https://openalex.org/W2131770134","https://openalex.org/W2091079248","https://openalex.org/W2417658445","https://openalex.org/W109232360"],"abstract_inverted_index":{"Anti-B4-blocked":[0],"ricin":[1,37,59,190],"is":[2,19,26,136,142],"an":[3,85],"immunotoxin":[4],"consisting":[5],"of":[6,34,98,115,133],"anti-B4":[7,16,35,57,127],"murine":[8],"monoclonal":[9,17],"antibody":[10,18,175,180],"and":[11,100,111],"\"blocked":[12],"ricin\"":[13],"toxin.":[14],"The":[15,88,130,139,151,167],"directed":[20],"against":[21],"the":[22,96],"CD19":[23],"antigen,":[24],"which":[25],"expressed":[27],"on":[28],"B-lymphocytes.":[29],"A":[30],"phase":[31],"II":[32],"study":[33],"blocked":[36,58,128,189],"toxin":[38],"in":[39,109,185,198],"patients":[40,55,105,117,135,148,199],"with":[41,47,75,118,200],"B-cell":[42],"chronic":[43],"lymphocytic":[44],"leukemia":[45],"(CLL)":[46],"residual":[48,101,201],"disease":[49],"after":[50,126,203],"chemotherapy":[51],"was":[52,156,171,183,191],"conducted.":[53],"Eleven":[54],"received":[56],"at":[60,79],"30":[61],"microg/kg":[62],"lean":[63],"body":[64],"mass":[65],"(LBM)":[66],"daily":[67],"by":[68],"continuous":[69],"infusion":[70,77],"for":[71,91],"7":[72],"days":[73],"followed":[74],"repeat":[76],"administered":[78],"14-day":[80],"intervals.":[81],"No":[82],"patient":[83],"achieved":[84,106],"objective":[86],"response.":[87],"major":[89],"reasons":[90],"failure":[92],"to":[93,154],"respond":[94],"were":[95,124,163],"presence":[97],"adenopathy":[99],"marrow":[102,110],"disease.":[103],"Three":[104,114],"immunophenotypic":[107],"response":[108],"peripheral":[112],"blood.":[113],"6":[116],"rearranged":[119],"IgH":[120],"and/or":[121,177],"Ig":[122],"kappa":[123],"germline":[125],"ricin.":[129],"median":[131,140,152],"follow-up":[132],"surviving":[134],"8.6":[137],"years.":[138],"survival":[141],"5.8":[143],"years":[144,158],"(range,":[145,159],"0.0-8.8).":[146],"All":[147],"have":[149],"progressed.":[150],"time":[153],"progression":[155],"0.8":[157],"0.3-3.0).":[160],"Infusion-related":[161],"toxicities":[162],"all":[164],"grade":[165],"1-2.":[166],"most":[168],"common":[169],"toxicity":[170],"transaminitis.":[172],"Human":[173],"antimouse":[174],"(HAMA)":[176],"human":[178],"antiricin":[179],"(HARA)":[181],"development":[182],"documented":[184],"2":[186],"patients.":[187],"Anti-B4":[188],"well":[192],"tolerated":[193],"but":[194],"had":[195],"limited":[196],"activity":[197],"CLL":[202],"chemotherapy.":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1969486352","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
